{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T05:39:04Z","timestamp":1792474744984,"version":"4.5.0"},"reference-count":0,"publisher":"Bentham Science Publishers Ltd.","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["CPPS"],"published-print":{"date-parts":[[2026,10,15]]},"abstract":"<jats:sec>\n                    <jats:title>Abstract:<\/jats:title>\n                    <jats:p>Conventional anti-inflammatory therapies, including nonsteroidal anti-inflammatory\ndrugs (NSAIDs) and corticosteroids, remain the mainstay of treatment for inflammatory disorders.\nHowever, their long-term use is often limited by adverse effects, insufficient target specificity, and\nan inability to achieve sustained resolution of chronic inflammation. Advances in the understanding\nof inflammatory signalling pathways have led to the identification of several promising protein targets\nfor the treatment of chronic inflammatory and autoimmune diseases. This review provides a\ncomprehensive overview of emerging therapeutic protein targets whose dysregulation contributes to\ninflammation and neuroinflammation, highlighting their molecular mechanisms, therapeutic potential,\nand current clinical relevance. Key targets discussed include inflammasomes, the JAK\u2013STAT\npathway, the IL-17\/IL-23 axis, specialized pro-resolving mediators (SPMs), the gut microbiota, epigenetic\nregulators, microRNAs, microglial activation, astrocyte dysfunction, the sphingosine-1-\nphosphate (S1P) signalling pathway, gasdermins, transient receptor potential (TRP) channels, and\nthe complement system. Current therapeutic strategies targeting these pathways include smallmolecule\ninhibitors, monoclonal antibodies, and other emerging biologics designed to achieve selective\nimmunomodulation. Collectively, these advances offer new opportunities for precision medicine\nby enabling more targeted control of inflammation while preserving essential host immune\nfunctions. Furthermore, the integration of multi-target therapeutic approaches, innovative drug delivery\nsystems, and personalized treatment strategies is reshaping the future of anti-inflammatory\ntherapy. Continued efforts to restore immune homeostasis without compromising protective immune\nresponses will be critical for the development of safer and more effective treatments for inflammatory\ndiseases.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.2174\/0113892037500525261002120730","type":"journal-article","created":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T05:00:11Z","timestamp":1792472411000},"source":"Crossref","is-referenced-by-count":0,"title":["Emerging Therapeutic Protein Targets of Inflammation: A\nComprehensive Review"],"prefix":"10.2174","volume":"27","author":[{"ORCID":"https:\/\/orcid.org\/0009-0006-6147-3516","authenticated-orcid":true,"given":"Suman","family":"Sinha","sequence":"first","affiliation":[{"name":"Institute of Pharmaceutical Research, GLA University, Mathura, Uttar Pradesh, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-5478-626X","authenticated-orcid":true,"given":"Ram","family":"Kumar","sequence":"additional","affiliation":[{"name":"Institute of Pharmaceutical Research, GLA University, Mathura, Uttar Pradesh, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-6607-0683","authenticated-orcid":true,"given":"Km","family":"Shainda","sequence":"additional","affiliation":[{"name":"Institute of Pharmaceutical Research, GLA University, Mathura, Uttar Pradesh, India"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"965","container-title":["Current Protein &amp; Peptide Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/0113892037500525261002120730","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/259565\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/0113892037500525261002120730","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T05:00:15Z","timestamp":1792472415000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/259565\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,15]]},"references-count":0,"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/0113892037500525261002120730","relation":{},"ISSN":["1389-2037"],"issn-type":[{"value":"1389-2037","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10,15]]}}}